Literature DB >> 17917769

Coronary involvement in infants with Kawasaki disease treated with intravenous gamma-globulin.

Noelia Moreno1, Ana Méndez-Echevarría, Jaime de Inocencio, Fernando Del Castillo, Fernando Baquero-Artigao, María Jesús García-Miguel, María Isabel de José, Javier Aracil.   

Abstract

AIM: To analyze the clinical spectrum and the incidence of coronary involvement in infants with typical Kawasaki's disease (KD). PATIENTS AND METHODS: A retrospective study was performed on children one year of age or younger diagnosed from February 1992 to January 2006 with typical KD. Children with incomplete forms of the disease were not included.
RESULTS: Twenty-five infants were diagnosed with KD during the study period. The median age of the patients was 10 months (range, 4-12 months). All children but one received intravenous gammaglobulin (IVIG), 84% before the 10th day of disease. Seven patients (28%) required the administration of more than one dose of IVIG, because persistence of fever. Coronary artery disease (CAD) was recorded in 6 cases (24%), five of them being boys. All patients with CAD were treated with ASA plus IVIG and 84% of them received this therapy within the first 10 days of the KD onset.
CONCLUSIONS: In spite of the exclusion of our study of incomplete presentations and of an early administration of IVIG in our patients, we have observed a high rate of infants who developed CAD, which is similar to the one reported in children who do not receive IVIG.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17917769     DOI: 10.1007/s00246-007-9068-0

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  19 in total

1.  Cardiac sequelae of Kawasaki disease in Japan: statistical analysis.

Authors:  Y Nakamura; Y Fujita; M Nagai; H Yanagawa; Y Imada; S Okawa; T Kawasaki; H Kato
Journal:  Pediatrics       Date:  1991-12       Impact factor: 7.124

2.  Incidence survey of Kawasaki disease in 1997 and 1998 in Japan.

Authors:  H Yanagawa; Y Nakamura; M Yashiro; I Oki; S Hirata; T Zhang; T Kawasaki
Journal:  Pediatrics       Date:  2001-03       Impact factor: 7.124

3.  Kawasaki disease in infants three months of age or younger.

Authors:  Chih-Hsien Chuang; Ming-Hsien Hsiao; Cheng-Hsun Chiu; Yhu-Chering Huang; Tzou-Yien Lin
Journal:  J Microbiol Immunol Infect       Date:  2006-10       Impact factor: 4.399

4.  Hospitalizations for Kawasaki disease among children in the United States, 1988-1997.

Authors:  Ruey-Kang R Chang
Journal:  Pediatrics       Date:  2002-06       Impact factor: 7.124

Review 5.  Adult Kawasaki disease: report of two cases and literature review.

Authors:  Pascal Sève; Katia Stankovic; Amar Smail; Denis Vital Durand; Guillaume Marchand; Christiane Broussolle
Journal:  Semin Arthritis Rheum       Date:  2005-06       Impact factor: 5.532

6.  [Incidence and clinical characteristics of Kawasaki's disease].

Authors:  M Martínez Ruiz; F del Castillo Martín; C Borque Andrés; M J García Miguel; M I de José Gómez; F Martínez Cortés; F Baquero Artigao
Journal:  An Pediatr (Barc)       Date:  2003-10       Impact factor: 1.500

7.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Pediatrics       Date:  2004-12       Impact factor: 7.124

8.  Kawasaki disease in infants less than one year of age.

Authors:  E A Rosenfeld; K E Corydon; S T Shulman
Journal:  J Pediatr       Date:  1995-04       Impact factor: 4.406

9.  Risk of coronary abnormalities due to Kawasaki disease in urban area with small Asian population.

Authors:  S T Shulman; J B McAuley; L M Pachman; M L Miller; D G Ruschhaupt
Journal:  Am J Dis Child       Date:  1987-04

10.  The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment.

Authors:  K Durongpisitkul; V J Gururaj; J M Park; C F Martin
Journal:  Pediatrics       Date:  1995-12       Impact factor: 7.124

View more
  6 in total

1.  Myocardial Layers Specific Strain Analysis for the Acute Phase of Infant Kawasaki Disease.

Authors:  Lucy Youngmin Eun; Ji Hong Kim; Jo Won Jung; Jae Young Choi
Journal:  Pediatr Cardiol       Date:  2016-07-09       Impact factor: 1.655

2.  Atypical Kawasaki disease.

Authors:  Vishal Puri; Madhuri Kanitkar
Journal:  Indian J Pediatr       Date:  2012-05-18       Impact factor: 1.967

3.  Promoter polymorphism (rs3755724, -55C/T) of tissue inhibitor of metalloproteinase 4 (TIMP4) as a risk factor for Kawasaki disease with coronary artery lesions in a Korean population.

Authors:  Ju Yeon Ban; Kyung Leem Yoon; Su Kang Kim; Sungwook Kang; Joo-Ho Chung
Journal:  Pediatr Cardiol       Date:  2008-12-02       Impact factor: 1.655

4.  Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease.

Authors:  Nagib Dahdah; Ana Siles; Anne Fournier; Jocelyne Cousineau; Edgard Delvin; Claire Saint-Cyr; Linda Spiegelblatt; Yvette Bonny; Michèle Vartian; Martine Montigny
Journal:  Pediatr Cardiol       Date:  2009-04-14       Impact factor: 1.655

5.  Clinical manifestations vary with different age spectrums in infants with Kawasaki disease.

Authors:  Hao-Chuan Liu; Chiao-Wei Lo; Betau Hwang; Pi-Chang Lee
Journal:  ScientificWorldJournal       Date:  2012-02-15

6.  Segmented coronary artery aneurysms and kawasaki disease.

Authors:  Mohammad Yoosef Aarabi Moghadam; Hojat Mortazaeian; Mehdi Ghaderian; Hamid Reza Ghaemi
Journal:  J Tehran Heart Cent       Date:  2011-05-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.